EFFECTOR To Wind Down Operations; Expects Securities To Be Delisted
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 24 2024
0mins
Source: NASDAQ.COM
- eFFECTOR Therapeutics Operations Termination: The company has terminated its employees and will wind down operations, seeking strategic alternatives for development programs.
- Leadership Changes: Craig Jalbert appointed as CEO, President, Treasurer, Secretary, and sole member of the board.
- Delisting Securities: eFFECTOR plans to voluntarily request a delisting of its securities with expectations of near-term delisting.
- Stock Performance: Shares of eFFECTOR are down 65% in pre-market trade on Monday.
- Disclaimer: The views expressed in the article are those of the author and not necessarily reflective of Nasdaq, Inc.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
